Sampo: Strong H1, Raised Guidance, and a New Growth Vector in Pensioner Health
Sampo's Resilient Engine
Sampo Oyj’s second-quarter results, reported on August 12, 2026, underscore a company executing on multiple fronts. Group CEO Morten Thorsrud opened the call by highlighting “broad-based and durable top-line growth, disciplined underwriting, and continued cost efficiency improvements across the Group” — Morten Thorsrud, Group CEO · 2026-08-12. The numbers back that up: like-for-like growth accelerated to 5% in Q2, underwriting result grew 5% on a currency-adjusted basis, and operating EPS rose 6%. The insurer raised its full-year guidance to 7–9% insurance revenue growth and 4–9% underwriting result growth, a clear signal of management confidence.
U.K. Pricing: Stabilization, Not Yet a Turn
On the U.K. motor market, Sampo is slightly more cautious than peers. While the market is improving, Thorsrud noted, “we've seen further stabilization in pricing trends, and we remain well positioned to accelerate our growth when the cycle now turns” — Morten Thorsrud, Group CEO · 2026-08-12. This aligns with his previous quarter's stance: “It's too early to say that it has changed totally, but we definitely see slight price increases” — Morten Thorsrud, Group CEO · 2026-05-06. The softer pricing environment is being partially offset by strong customer additions (180,000 in Q2, +13% YoY) and a focus on data-driven underwriting. However, claims inflation is a growing watch item, particularly from spare-part costs tied to the Strait of Hormuz situation. This connects to a broader global theme of higher inflation and supply-chain disruption, and Sampo is proactively adding extra pricing and reserves.
Digital and Cost: The Moat Deepens
A key differentiator is Sampo's accelerating digital transformation. The If mobile app now has 1.8 million downloads, with >70% of claims reported digitally. The AI-powered virtual agent, IfGPT, has been expanded from Denmark into Sweden and Norway, and a new If Vet app launched across the Nordics. These investments are directly supporting the cost ratio improvement – management reaffirmed the 40 bps annual reduction target, underpinned by Topdanmark synergies now at EUR 73 million. As Thorsrud explained, the efficiency gains are structural: “We've been realizing the synergies quite a bit faster than anticipated,” though he cautioned that quarterly cost movements can be lumpy.
Nordic Commercial and a New Health Mandate
The Nordic Commercial segment emerged as the fastest-growing in Q2 at 8.6% like-for-like, driven by robust SME volume growth (over 5%) and several larger customer wins. The standout is a major personal insurance agreement in Denmark providing comprehensive healthcare to 40,000 pensioners – an exciting expansion into a new demographic. Combined with the continued strength in the SME market, this suggests durable momentum beyond one-off deals. Thorsrud noted that the Q2 growth was “more of a normalization” after a softer Q1, and he expressed confidence in sustained traction.
We now expect to achieve 7% to 9% insurance revenue growth and to deliver 4% to 9% underwriting result growth.
Solvency and Investment Rebound
CFO Lars Beck highlighted a sharp rebound in investment returns, with the core portfolio posting net gains of EUR 240 million in Q2, “roughly evenly split between fixed income and equities” — Lars Beck, Group CFO · 2026-08-12. This reversed Q1's mark-to-market loss. Solvency remained robust at 174%, though the symmetric adjustment now stands at 9% (near the 10% cap); ex-adjustment, coverage would be 180%. The Danish workers' comp court ruling, a prior overhang, remains contained – management reiterated that old claims are covered by ENID reserves, and the current-year impact is fully reserved in the outlook.
In summary, Sampo is delivering on its strategic priorities: organic growth across geographies, cost leadership, and digital innovation. The new pensioner health mandate is a fresh growth vector that could open a broader market, while the U.K. cycle remains the key swing factor. With raised guidance and a strong capital position, the risk-reward looks favorable, though investors should watch claims inflation and competitive dynamics in the U.K.